Innovation
26 patent families (8 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 2,057 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 9 |
| 2022 | 14 |
| 2023 | 13 |
| 2024 | 9 |
| 2025 | 10 |
| 2026 | 4 |
Social engagement
Social engagement: 8.9K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
11 investors on record; lead investors include Sofinnova Partners, Morningside, Orbimed.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 55% |
| Private equity | 1 | 9% |
| Accelerator & incubator | 1 | 9% |
| Bank & private debt | 1 | 9% |
| Other / undisclosed | 2 | 18% |
Recent activity
19 Jun 2026
Event
BIO International Convention 2026
3 Jun 2026
Leadership hire
Chairman
4 May 2026
Event
Bio€quity Europe